Perry Karsen

Executive Chairman at Nitrome Biosciences, Inc.

Perry Karsen

Perry Karsen

Executive Chairman at Nitrome Biosciences, Inc.

Overview
Career Highlights

Celgene Corp.
Celgene LLC
Nitrome Biosciences, Inc.

RelSci Relationships

5219

Number of Boards

26

Birthday

1955

Age

66

Contact Data
Trying to get in touch with Perry Karsen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Perry Karsen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer & Director at Stalar 4, Inc.

Relationship likelihood: Strong

Former Venture Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Intellia Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

Vice Chairman at The National Health Museum

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Nkarta, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Relationship likelihood: Strong

Professor at Duke University

Relationship likelihood: Strong

Former Chief Executive Officer, Director at RespireRx Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Perry Karsen
Potential Connections via
Relationship Science
You
Perry Karsen
Executive Chairman at Nitrome Biosciences, Inc.
Education
Masters of Management
Class of 1988

The Kellogg School of Management (The Kellogg School or Kellogg) is the business school of Northwestern University in Evanston, Illinois, with additional campuses in downtown Chicago, Illinois and Miami, Florida. Kellogg offers full-time, part-time, and executive programs, and partners with schools in China, France/Singapore, India, Hong Kong, Israel, Germany, Canada, and Thailand.Founded in 1908 in downtown Chicago as a part-time evening program, the school was chartered to educate business leaders with "good moral character.

Master's Biology
Class of 1979

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

BS Biological Sciences
Class of 1977

The University of Illinois at Urbana–Champaign is a public research-intensive university in the U.S. state of Illinois. It is the flagship campus of the University of Illinois system. The University of Illinois at Urbana–Champaign is the second oldest public university in the state (after Illinois State University), and is a founding member of the Big Ten Conference. It is considered a Public Ivy and is a member of the Association of American Universities.

Memberships
Career History
Executive Chairman
Current

Nitrome Biosciences, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY.

Current

Intellia Therapeutics, Inc. engages in the development of gene editing-based therapies. It provides scientific expertise, clinical development, and intellectual property position to unlock broad therapeutic applications of CRISPR or Cas9 genome editing and develop a potential new drug class. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Venture Partner
2016 - Prior

Third Rock Ventures invests in companies located in the US. The firm targets operating in the fields of healthcare sector. It provides financing for early-stage capital requirements. It also acts as a lead investor.

Boards & Committees
Chair, Board of Directors
2020 - Current

At Graphite Bio, they are rapidly building a next-generation gene editing company that is driven to apply their breakthrough technology with urgency to advance gene replacement therapies and cures for people living with serious diseases. They stand apart through our ability to harness natural and highly precise cellular DNA repair machinery to achieve high efficiency, targeted gene integration to correct the underlying causes of diseases.

Independent Director
2020 - Current

Jiya Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded in August 2020 and is headquartered in Palo Alto, CA.

Executive Chairman
2020 - Current

Nitrome Biosciences, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY.

Member, Emerging Companies Section Governing Board
Current

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Member, Board of Overseers
Current

WE PRESERVE AND CELEBRATE OUR SCIENTIFIC AND TECHNOLOGICAL CULTURE AND MAKE IT ACCESSIBLE FOR INVESTIGATION AND KNOWLEDGE CREATION.

Director
Current

The Gladstone Institutes is an independent and nonprofit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Gladstone researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the stem cell breakthrough of one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration. Founded in 1979, Gladstone is affiliated with the University of California, San Francisco (UCSF) and is located in San Francisco, adjacent to UCSF’s Mission Bay campus. Approximately 450 staff members—including more than 300 scientists—work at Gladstone.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 - $499
2009

HOMEFRONT'S MISSION IS TO END HOMELESSNESS IN CENTRAL NEW JERSEY BY HARNESSING THE CARING, RESOURCES AND EXPERTISE OF THE COMMUNITY. THE ORGANIZATION LESSENS THE IMMEDIATE PAIN OF HOMELESSNESS AND HELPS FAMILIES BECOME SELF-SUFFICIENT. HOMEFRONT WORKS TO GIVE ITS CLIENTS THE SKILLS AND OPPORTUNITIES TO ENSURE ADEQUATE INCOMES, AND WORKS TO INCREASE THE AVAILABILITY OF ADEQUATE, AFFORDABLE HOUSING. HOMEFRONT HELPS HOMELESS FAMILIES ADVOCATE FOR THEMSELVES INDIVIDUALLY AND COLLECTIVELY.

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
8th Annual Columbia Business School Health Conference

Speaker
New York City, NY
2013 UBS Global Healthcare Conference

Speaker
18th Annual Wharton Health Care Business Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Perry Karsen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Perry Karsen's profile does not indicate a business or promotional relationship of any kind between RelSci and Perry Karsen.